Delivery Order SPE2DR25D3301-SPE2DR26F19UN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,204.52 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, effective December 3, 2025, with ultimate completion by December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to support federal pharmaceutical supply needs. The contract was performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on November 6, 2025, with a ceiling value of $1,092.57. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made on a competitive, non-set-aside basis and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,409.04 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of December 10, 2025. This is a firm fixed-price, non-set-aside contract representing a single delivery order under the company's larger pharmaceutical supply agreement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,197.63 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger contract vehicle with the...
- The Defense Logistics Agency awarded a $1,760.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for Valtoco 10 mg nasal sprays, with completion scheduled for November 17, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $2,395.14 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of November 7, 2025. The award, issued on November 6, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,613.58 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with a completion deadline of September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,093.62. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a $1,129.62 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 23, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19UNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,324.67 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of December 22, 2025. This firm fixed-price contract, awarded competitively without a set-aside designation, represents a direct purchase order fulfilling pharmaceutical supply requirements for federal medical procurement. The awardee will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Health Agency and other federal healthcare systems, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies supporting military healthcare programs globally. The current delivery order for Valtoco, a seizure rescue medication, exemplifies the company's role in providing specialty pharmaceuticals and brand-name drugs through the DLA's Pharmaceutical Prime Vendor program, which serves military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/18/25 |